| Machida N, Yoshino T, Boku N, et al.
Impact of baseline sum of longest diameter in target lesions by RECIST on survival of patients with metastatic colorectal cancer. [Journal Article]
Jpn J Clin Oncol 2008 Oct; 38(10):689-94.
Abstract | Full Citation | | Scartozzi M, Galizia E, Chiorrini S, et al.
Arterial hypertension correlates with clinical outcome in colorectal cancer patients treated with first-line bevacizumab. [JOURNAL ARTICLE]
Ann Oncol 2008 Oct 7.
Abstract | Full Citation | Publisher Full Text | Find Related Articles | | Norden AD, Drappatz J, Wen PY
Antiangiogenic therapy in malignant gliomas. [Journal Article, Research Support, Non-U.S. Gov't]
Curr Opin Oncol 2008 Nov; 20(6):652-61.
Abstract | Full Citation | | Yi SY, Park YS, Kim HS, et al.
Irinotecan monotherapy as second-line treatment in advanced pancreatic cancer. [JOURNAL ARTICLE]
Cancer Chemother Pharmacol 2008 Oct 7.
Abstract | Full Citation | | Fornaro L, Masi G, Bursi S, et al.
A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer. [JOURNAL ARTICLE]
Cancer Chemother Pharmacol 2008 Oct 7.
Abstract | Full Citation | | Goff LW, Rothenberg ML, Lockhart AC, et al.
A phase I trial of irinotecan alternating with epirubicin in patients with advanced malignancies. [Journal Article, Research Support, Non-U.S. Gov't]
Am J Clin Oncol 2008 Oct; 31(5):413-6.
Abstract | Full Citation | | Alberts SR, Wagman LD
Chemotherapy for Colorectal Cancer Liver Metastases. [JOURNAL ARTICLE]
Oncologist 2008 Oct 6.
Abstract | Full Citation | | Morise Z, Sugioka A, Hoshimoto S, et al.
Patient with advanced intrahepatic cholangiocarcinoma with long-term survival successfully treated with a combination of surgery and chemotherapy. [Journal Article]
J Hepatobiliary Pancreat Surg 2008; 15(5):545-8.
Abstract | Full Citation | Find Related Articles | | de Groot JF, Yung WK
Bevacizumab and irinotecan in the treatment of recurrent malignant gliomas. [Journal Article]
Cancer J 2008 Sep-Oct; 14(5):279-85.
Abstract | Full Citation | Find Related Articles | | Tahara M, Shirao K, Boku N, et al.
Multicenter Phase II Study of Cetuximab Plus Irinotecan in Metastatic Colorectal Carcinoma Refractory to Irinotecan, Oxaliplatin and Fluoropyrimidines. [JOURNAL ARTICLE]
Jpn J Clin Oncol 2008 Oct 4.
Abstract | Full Citation | Find Related Articles |   |
|
| |
Advertise on this site.
|
